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Abstract: The early diagnosis of diseases, e.g., Parkinson’s and Alzheimer’s disease, diabetes, and
various types of cancer, and monitoring the response of patients to the therapy plays a critical
role in clinical treatment; therefore, there is an intensive research for the determination of many
clinical analytes. In order to achieve point-of-care sensing in clinical practice, sensitive, selective,
cost-effective, simple, reliable, and rapid analytical methods are required. Biosensors have become
essential tools in biomarker sensing, in which electrode material and architecture play critical roles
in achieving sensitive and stable detection. Carbon nanomaterials in the form of particle/dots,
tube/wires, and sheets have recently become indispensable elements of biosensor platforms due to
their excellent mechanical, electronic, and optical properties. This review summarizes developments
in this lucrative field by presenting major biosensor types and variability of sensor platforms in
biomedical applications.
Keywords: biosensors; biomarker; cancer detection; graphene; carbon nanotubes; graphene oxide;
quantum-dot
1. Introduction
Diseases present continuous danger to human life and well-being, and cancer is one of the leading
causes of human death. The early detection and precise diagnosis of the onset of a disease is the most
promising approach to accelerate healing processes or to improve survival of patients [1–3]. Clinical
treatment and monitoring of disease recurrence after treatment also require continuous screening.
To this end, fast, selective, reliable, and cheap analytical methods are required, which can be easily
and routinely used even by unprofessional personnel. The human body responds to infections and
development of diseases variously by producing and/or changing or fluctuating levels of certain
biomolecules in the human body, and these biomarkers can be used for early detection and monitoring
of diseases. Disease biomarkers belong to an important group of materials whose concentration
in serum and tissue changes during the onset of a disease [1]. Taking samples from body fluids,
namely urine, blood, saliva, tears, or sweat, is relatively easy, non- or minimally invasive, and provide
possibility for frequent sampling thus continuous monitoring. The detection of biomarkers in body
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fluids, however, is challenging, because their concentration is often very low and they present in
complex biological assay. Traditional assay methods such as enzyme-linked immunosorbent assay [4],
radioimmunoassay [5], electrophoretic immunoassay [6], mass spectrometric immunoassay [7],
and immunofluorimetric immune-polymerase chain reaction (PCR) assay [8] have some disadvantages,
namely time-consuming measurement, hazardous to health, and require highly trained operators
or expensive and sophisticated instrumentation. Therefore, the development of rapid, simple, and
sensitive immunoassay methods for body fluid biomarker detection has a great clinical significance in
the diagnosis of various diseases. Electrochemical and optical biosensors are particularly attractive for
biomarker detection due to their high sensitivity, relatively easy fabricating and operating procedures,
and the potential to be miniaturized. Carbon nanomaterials offer attractive opportunities for improving
sensor performances due to their excellent electric and mechanical properties, high specific surface
area, and biocompatibility. The incorporation of carbon nanomaterials into biosensor platforms is now
a rapidly growing area of biosensor design. The most widely used carbon nanomaterials to date are
nanotubes (single-walled (SWCNT) and multiple-walled (MWCNT)) and graphenes (graphene (GR),
graphene oxide (GO), and reduced graphene oxide (rGO)), but carbon quantum-dots (QD) emerges as
novel materials for sensor construction. In this review, we focus on the merits of carbon nanomaterials
for fabrication of biosensor devices that are used as analytical tools for biomarkers detection.
The analysis of multiple biomarkers, those associated with cancers or diseases, are of vital importance
for early diagnosis of diseases and clinical therapy. The review also outlines some limitations and
drawbacks of these developments considering practical application of nanocarbon-based biosensors
for point-of-care diagnostics.
2. Construction of Biosensors for Biomarkers Detection
Biosensor is an analytical tool consisting of biologically active material used in close conjunction
with a device that convert a biochemical signal into quantifiable signal. A typical biosensor
configuration has three-element system: a bioreceptor that is responsible for selectivity of the device
(e.g., enzymes, antibodies, lipid), a transducer that translates the physical or chemical change by
recognizing the anatyle, and a signal-processing unit (signal output). Due to the often extremely
low biomarker concentration and disease selective detection, sensitivity and selectivity are of
vital importance. Other requirements include repeatability, stability, cost-effectiveness, reusability,
and disposability. Common transducing elements incorporated in the biomarker biosensor platform
thus far include electrochemical, optical, or mass-sensitive elements which can generate measurable
current, light, or frequency signals. Overwhelming majority, ca. 89%, of biomarker biosensors
developed to date are electrochemical sensors, 9% are fluorescence sensors and 2% are piezoelectric
sensors (see Tables 1–5 below). When the analyte interacts with bioreceptor, a quantifiable signal is
generated and that can be monitored by using various sensing techniques [9–13].
2.1. Electrochemical Biosensors
These biosensors are based on electrochemical techniques in which analyte sensing is made by
measuring the electrical response as an analyte reacts electrochemically with the surface of the working
electrode of the sensor [14]. In general, a linear relationship between the analyte concentration and
sensor response is required for practical applications. If the analyte is electroactive, e.g., glucose
and dopamine, it may be detected directly with or without using a catalyst on the electrode surface.
If electroactivity is insufficient or selectivity requires, the detection of the target is possible by selecting
an electroactive species (e.g., hexacyanoferrate, hydrogen peroxide, etc.) and capturing the target onto
the electrode surface where it acts as an inert electron and mass transfer blocking layer and hinders
the diffusion of electroactive species toward the electrode surface. The sensitivity of the electrode
can be increased by selectively attaching labels to the captured target (sandwich-type arrangement),
which catalyse the redox reaction of the electroactive species (see Figure 1). Basic questions concerning
sensitivity and selectivity are, respectively, how to increase electron transfer toward the electrode
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and how to make the electrode reaction specific to a selected target. In order to increase electrode
response magnitude, increasing the electrode surface, incorporating good conducting materials into
the electrode modifying thin film layer, and/or catalysing the redox reaction are frequently applied.
Although, in general, larger surface area results in increased current response of a target due to
increased number of reactive sites, increased current is offset by an increased background current
which limits the sensitivity [15]. Limit of detection (LOD), usually defined as the lowest analyte
concentration where the signal is three times larger than the noise, is more useful for characterizing
sensor performance than sensitivity in terms of applicability. The selectivity of the sensor is a key issue,
and anchoring selective target capture target antibodies on the electrode surface is generally applied.
This is the method of choice for cancer sensors where the concentration dependent cancer antigen
detection is the major task. The formation of antibody-antigen complex in these sensors decreases
the peak current of the redox pair label linearly with increasing antigen concentration. A basic DNA
biosensor is usually designed by the immobilization of single stranded oligonucleotide on sensing
substrates to recognize its complementary (target) DNA sequence via hybridization. The hybridization
event is then converted into a readable signal by the transducers. After immobilizing target capture
biomolecules or molecules on the sensor surface, it is necessary to block remaining binding sites on
the surface in order to prevent nonspecific binding of the target. Depending on the surface property
and binding strategy, bovine serum albumin (BSA), polyoxyethylenesorbitan monolaurate (Tween 20),
and thiolated molecules on gold surfaces are widely used. Carbon nanoparticles (NP) possess excellent
electrical properties and large specific surface area thus they are ideal components of biosensor
platforms. There are well-established methods for their synthesis for sensor applications [15–18].
These are based on either building up nanoparticles from small molecular building blocks formed by
the decomposition of a precursor (bottom-up methods, namely chemical vapour deposition (CVD)
and wet chemical synthesis) or splitting bulky and layered compounds into single-layer nanomaterials
(top-down methods, namely chemical, liquid, or mechanical exfoliation). Pristine carbon nanoparticles,
in general, are chemically inert, and it is necessary to activate their surface for functionalization and for
facilitating composite formation and immobilizing biomolecules via these functional groups [19–21].
Functionalization, however, may introduce a large number of defects, what reduce the electrical
conductivity and corrosion resistance of nanoparticles. Extensive reduction of the carbon surface can
lead to increased background current and reduced LOD [14,15]. An alternative way of functionalization
is the noncovalent functionalization of carbon NPs, e.g., with metal or metal oxide NPs, biomolecules,
biopolymers, and organic polymers. These materials cause little or no structural damage to carbon
NPs, and composites obtained promotes electron transfer due to synergistic effects and introduce a
large amount of binding sites for capturing biomolecules. Gold NPs, for example, are frequently used
in biosensor construction because AuNPs are excellent electric conducting materials and it is relatively
easy to immobilize thiolated molecules on their surface by chemisorptions. Carbon nanomaterials are
generally used (i) in the recognition element of the sensor, where they provide binding sites for target
biomarkers or molecules capturing target biomarkers, (ii) in the transducer component that converts
the detected molecular interaction on the electrode surface into a measurable signal, and (iii) labels
for target biomarkers in signal amplification. The biosensor performance strongly depends on these
components, and can be tuned by modifying them. In general, the LOD can be increased if less noise
is observed compared to the current in the working electrode upon analyte interaction.
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Figure 1. Fabrication steps of the working electrode of the sandwich-type squamous cell carcinoma
antigen (SCC-Ag) biosensor by modifying a glassy carbon electrode (Ag = antigen, Ab = antibody,
N-GS = nitrogen-doped graphene sheet, BSA = bovine serum albumin) [22]. Copyright 2013.
Reproduced with permission from Elsevier.
Immobilizing target capture antibodies on the electrode surface plays an important role in
biosensor construction. Large fraction of the known biomarker antibodies, e.g., proteins, has amine
groups, and these can be immobilized covalently by using these amine residues and carboxyl functional
groups of carboxylated carbon NPs or modifiers on the sensor surface. Molecules containing both
the carboxyl and thiol groups can be used as linkers to functionalize gold and silver nanoparticles.
Carboxyl group, however, has to be activated for this reaction. The most widely applied activation
method is based on the application of 1-ethyl-3-(3-dimethylaminopropyl)-carbodiimide (EDC) and
N-hydroxysuccinimide (NHS) (EDC/NHS coupling, see e.g., [23]). Amino-groups of capture
antibodies and amino-functionalized carbon NP composites, e.g., amino-groups of chitosan, are usually
linked using glutaraldehyde (GLA coupling, see e.g., [24]). Other less frequently used methods to
immobilize biomarker capture antibodies utilizes biospecific lectin-sugarprotein interaction [25],
biotin-streptavidin interaction [26], and bonding between amino groups and Pt [22].
2.2. Optical-Based Biosensors
These sensors are based on detecting changes in the emission of light upon target-recognition
element interaction. Carbon NPs, especially graphene derivatives, are efficient fluorescence
quenchers [9]. The solubility of GO and rGO, and their functionalized derivatives in water provides
possibility for their application in aqueous environments, namely in biological samples. A GO or rGO
based fluorescence sensor, in general, is based on a fluorophore covalently attached to a target capture
probe, what is capable to adsorb non-covalently to GO, but released from the GO surface upon binding
to the target. Adsorption leads to quenching the fluorescence, but it is restored upon target-capture
probe interaction. The most typical example is a labelled single stranded DNA (ssDNA) capture probe
complementary to target ssDNA; the capture ssDNA adsorbs to GO, but the double stranded dsDNA
desorbs from the GO surface after target-capture probe hybridization. This fluorescence method is
attractive for bioassay application, because it is simple, the signal intensity is high, the background
noise is low, and it is able to realize multiple target and multicolour detection [27]. Although there
are several variants of this method [27], most of these sensors thus far are based on ssDNA capture
antibodies. The application of optical sensors for disease and cancer biomarker detection is relatively
rare to date, which may be explained by the fact that the majority of the currently known cancer and
disease biomarkers are not DNA derivatives. Inspired by GO-based DNA biosensors, a GO platform
for sensing collagen triple helix was developed recently [28]. The biosensor is based on dye-labelled
single stranded collagen (ssCOL) peptide probe, what adsorbs to GO and targets its complementary
collagen peptide. The working principle, identical to DNA sensors, is shown in Figure 2.
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involves  the  fabrication  of  a  homogeneous  biocompatible  film  on  the  QCM  surface  and  the 
immobilization of  target capture antibodies on  this  surface. The piezoelectric  immunosensors are 
reported to be one of the most sensitive devices developed to date, being capable of detecting antigens 
in  the picogram  range. Moreover,  this  type  of device  is  believed  to have  the potential  to detect 
antigens in the gas phase as well as in the liquid phase. 
Although QCM biosensors possess high  sensitivity,  real‐time output,  label‐ or  radiation‐free 
entities, and simplicity, they are hardly applied for carbon NP based biomarker sensor constructions 
to date, possibly due  to  the difficulty  in obtaining a homogeneous biocompatible  film with good 





(e.g.,  glucose,  dopamine,  and  uric  acid), RNAs,  peptides,  proteins, DNAs,  polysaccharides,  and 
lipids. The detection of antigens is especially important for cancer diagnosis. Carbon nanomaterials 
offer novel  routes  to design new biosensors due  to  their unique properties. Functionalization or 
hybridization of these materials with biopolymers, organic polymers, metal oxide nanoparticles (NP), 
and metal NPs  expand  application  possibilities  due  to  synergistic  effects  and  introduce  a  large 
amount of binding sites for capturing biomolecules or immobilizing biomarker capture antibodies. 
Most widely used biomarker capture probes are ssDNAs, e.g., aptamers, and proteins, e.g., antigen 
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2.3. iezoelectric- ased iosensors
Se sor devices are based on piezoelectric crystals, mainly quartz that vibrates under the influence
of an electric field [11]. Since the mass of the adsorbed material to the crystal is ro ortio al
to the resonance frequency of the crystal, the concentration dependent binding of biomarkers
can be monitored. The construction of quartz crystal microbalance (QCM) biosensor platform,
i general, involves the fabrication of a homogeneous biocompatible film on the QCM surface and
the immobilization of target capture antibodies on this surface. The piezoelectric i nosensors are
reporte to be one of the ost sensitive evices evelope to ate, being capable of etecting antigens
in the picogram range. Moreover, this type of device is believed to have the potential to detect antigens
in the gas phase as well as in the liquid phase.
lthough biosensors possess high sensitivity, real-ti e output, label- or radiation-free
entities, and si plicity, they are hardly applied for carbon NP based biomarker sensor constructions to
date, possibly due to the difficulty in obtaining a homogeneous biocompatible film with good adhesion
abilities to transducer components and relatively high cost [29]. In conclusion, this PZ biosensors still
need considerable development before they can be considered to become a routine anatical tool.
3. Detection of Cancer and Disease Biomarkers
Biomarkers present in body fluids include a wide variety of materials such as small molecules
(e.g., glucose, dopamine, a d uric aci ), RNAs, pepti es, p oteins, DNAs, polysaccharides, and lipid .
The detection of antigens is especially important for cancer diagnosis. Carbon nanomaterials off r novel
routes to design new biosensor due to their unique properties. Functionalization or hybridizat on
these materials with biopolymers, organic polymers, metal oxide nanoparticles (NP), and metal
NPs exp nd application possibil ies due to syner istic effects and introduc a large amount of
binding sites for ca turing biomolecules or immobilizing biomarker apture antibodies. Most widely
used biomarker capture p obes a e ssDNAs, e.g., apta ers, and proteins, e.g., antigen ti ies.
Immunoassays based on th antibody-antigen, aptamer-RNA, apta er-protein, and protein-protei
i teract on are the mo t important analytical methods for the quantitative detection of biomarkers.
3.1. CNT-Based Biomarker Biosensors
CNTs promote electron transfer and possess high stability, low background noise, rapid electrode
kinetics, and excellent biocompatibility. Therefore, CNTs are widely used in various biosensor
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constructions for preparing the sensing layer of the sensor and for fabricating labels for signal
amplification in sandwich-type biosensors [19,30–32].
3.1.1. CNT-Based Biosensors for Cancer Biomarker Detection
Prostate-specific antigen (PSA) is a single chain glycol-protein, and it is the most widely used
biomarker for prostate cancer. Several CNT-based biosensors were constructed for PSA detection
using anti-PSA antibodies as recognition elements on the sensor surface (Table 1). These sensor
platforms include microelectrode arrays modified with SWCNTs [33], cross linked starch functionalized
MWCNT-gold NP nanocomposite film [34], SWCNT forest-primary antibody platform with multi-label
secondary antibody-MWCNT-horseradish peroxidase (HRP) bioconjugate labels [35], and gold
NPs functionalized polypyrrole (PPy)@MWCNT nanocomposite with HRP-conjugated anti-PSA
labels [36]. The LOD of sensors gradually decreased to 1 pg/mL by incorporating AuNPs and
polymers into the sensor platform and applying target labels. Osteopontin (OPN), a phosphoprotein,
is also a prostate cancer biomarker. OPN immunosensors were fabricated by Lerner et al. [37] and
Sharma et al. [38] by covalently attaching monoclonal anti-OPN antibodies to CNTs of a field-effect
transistor (FET) and a transparent chemiresistor-type sensor, respectively. These sensors exhibited an
antigen-specific, concentration dependent response, wide linear range, and high sensitivity (Table 1).
MicroRNAs (miRNAs), small non-protein-coding ss-RNA molecules consisting of 18 to 30 nucleotides,
are biomarkers for various human cancers. miRNA-21 and miRNA-141, for example, are prostate
cancer biomarkers. An ultrasensitive miRNA-21 biosensor based on layer-by-layer assembly of
SWCNT, nanodiamonds (NDI), SWCNT, and AuNP on gold electrode was constructed by Liu et al. [39].
Tetrahedron-structured probe (TSP) capture DNAs were immobilized on the AuNPs through Au-S
bonds in order to capture miRNAs by hybridization. The signal was amplified by DNA functionalized
AuNPs modified with long hemin-G-quadruplex DNAzyme nanowires. Two miRNA-141 biosensors
were constructed by Tran et al. [40,41] based on amino-modified 22-mer DNAs as miRNA capture
probes. The label-free sensor [40] fabricated by co-electrooxidation of 5-hydroxy-1,4-naphthoquinone
(JUG) and 3-(5-Hydroxy-1,4-dioxo-1,4-dihydronaphthalen-2(3)-yl) propanoic acid (JUGA) monomers
on MWCNT modified glassy carbon electrode (GCE), and the sandwich-type electrode [41], based
on MWCNT-rGO composite modified gold screen-printed electrode (GSCE) and HRP-conjugated
secondary antibody labels, exhibited comparable LOD and linearity range (Table 1). A sensitive
and selective biosensor for the detection of miRNA-122a was constructed by Ramnani et al. [42]
by integrating an extremely sensitive SWCNT-FET transducer and a highly selective biorecognition
element of Carnation Italian ringspot virus p19 binding protein. Tian et al. [43] developed a lung-cancer
related let-7 miRNA sensor based on CNT enhanced label-free detection and hairpin (HP) DNA
probe triggered solid-phase rolling-circle amplification (RCA). The sensor exhibited ultrasensitive
detection limit and excellent specificity for let-7 miRNA. Li et al. [44] constructed a sensitive miRNA-24
sensor by drop-casting MWCNTs on GCE and immobilizing aminated capture probe ss-DNAs on the
electrode surface.
Carcinoembryonic antigen (CEA) is an important biomarker for the diagnosis of cervical
carcinomas, and pancreatic, gastric, colorectal, and lung cancer. Various CNT-based electrochemical
sensors were developed for CEA detection utilizing anti-CEA antibodies as target recognition elements.
Sensor platforms include microelectrode arrays modified with chitosan (CS)-MWCNT-thionine (Thi)
hybrid film [45], conducting paper (CP) electrode based on CNT-poly(3,4-ethylenedioxythiophene):
poly(styrenesulfonate) (PEDOT:PSS) composite [46], GCE modified by multi-layer films made
from Prussian Blue (PB) NPs and rGO-MWCNT composites and AuNPs [47], GCE modified by
multi-layers of PB NPs and MWCNT-polyethyleneimine (PEI)-AuNP composites and chitosan
with AuNPs [48], and GCE modified by layer-by-layer (LbL) assembly of positively charged
CNTs wrapped by poly(diallyldimethylammonium chloride) (PDDA) and negatively charged
poly(sodium-p-styrene-sulfonate) (PSS) [49]. The latter three multilayer-film modified sensors
exhibited comparable sensitivity and linearity range (Table 1). Constructing relatively simple sensor
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surfaces by immobilizing anti-CEA antibodies directly on gold electrode via cysteine linkers [50] or
on MWCNT modified SPCE [51], but using labels on targets improved sensor performances. Labels
for the modified gold electrode were prepared by coating MWCNTs with PDDA and depositing HRP,
ConA, and HRP-labelled anti-CEA on the nanoparticle surface. Labels for the SPCE electrode were
prepared by immobilizing secondary CEA antibodies and glucose oxidase (GlOx) on gold nanorods.
Applying CNT composites and metal NPs in sensor surface modification, as well as target labels
further improved sensor performances (Table 1). Deng et al. [52] used PtNP dotted rGO-MWCNT
composites as modifiers of the electrode surface and carbon dot (CD) functionalized Pt/Fe-NPs as
nanolabels. Hu et al. [53] fabricated a photoelectrochemical biosensor based on MWCNT-Congo red
(CR)-C60 hybrid labels and poly(p-aminobenzoic acid) (PABA)-MWCNT nanocomposite-modified
indium-tin-oxide (ITO) electrode. Li et al. [54] developed an ultrasensitive immunosensor with
LOD of 0.2 pg/mL based on PdPt nanocages/amino-functionalized MWCNTs as signal labels and
APTES-functionalized graphene sheets (NH2-GS) as transducing materials (see Figure 3).
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Figure 3. Illustration of the fabrication steps and working principle of the sand ich-type
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Carcinoma antigen-125 (CA125) is the most frequently used clinical biomarker for ovarian cancer.
Paul et al. [55] and Chen et al. [56] constructed label free CA125 biosensors by modifying GCE
with MWCNTs embedded ZnO nanowire film and MWCNT-Nafion composite film incorporating
tris(2,2′-bipyridyl)cobalt(III) (Co(bpy)33+) mediator and AuNPs, respectively, as well as anti-CA125
antibodies. The GCE/MWCNT-ZnO/anti-CA125 sensor exhibited much higher sensitivity with a LOD
of 0.00113 U/mL. Carbohydrate antigen 19-9 (CA 19-9) is a marker of pancreatic, colorectal, and hepatic
carcinomas. Ding et al. [29] developed a piezoelectric immunoassay for CA 19-9 detection by
immobilizing anti-CA 19-9 antibodies on QCM modified by poly-L-lysine/hydroxyapatite/MWCNT
composite (PLL/HA/MWCNT). The tumour suppressor gene TP53 and protein p53 (AGp53) mutations
are important early diagnostic cancer markers. A sensitive DNA biosensor was constructed by
Fayazfar et al. [57] for detecting TP53 mutation. The working electrode of the sensor was prepared
by synthesizing well-aligned MWCNTs on Ni-deposited Ta plate by CVD, electrodepositing AuNPs,
and finally immobilizing 26-mer thiolated DNAs on AuNPs to capture target. Wang et al. [58]
developed an enzyme electrocatalytic sandwich-type immunosensor for AGp53 detection. A GCE
was modified by MWCNT-Nylon 6 (PA6)-polythionine (PTH) composite nanofibers and anti-AGp53
capture antibodies. The signal was amplified using HRP-conjugated secondary polyclonal anti-AGp53.
K-ras gene mutation is highly associated with colorectal cancer. Wang et al. [59] constructed a specific
K-ras bioensor by electrospinning MWCNTs doped nylon 6 (PA6) nanofibers onto a GCE, modifying
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the electrode surface by thionine electropolymerization, and immobilizing a 20-mer ssDNA1 to capture
K-ras gene. A sandwich format of ssDNA1/K-ras gene/AuNP-20-mer ccDNA2 was prepared for
signal amplification, and this latter was further increased by building a network-like structure between
Au-NPs using thiocyanuric acid. High level of circulating galectin-3, a β-galactoside-binding protein,
is correlated with an increased potential for malignancy. Park et al. [60] constructed a FET biosensor to
detect galectin-3 using D-(+)-galactose-conjugated SWCNTs as chemical probes. The sensing platform
was prepared by drop casting SWCNTs linked with D-(+)-galactose on a Mo electrode prepatterned
SiO2 substrate, printed using conventional photolithography.
Mucin 1 (MUC 1), a heavily O-glycosylated protein, is strongly expressed in the early stage of
breast cancer. Chen et al. [61] developed a sandwich-type aptasensor for MUC 1 detection. The sensor
was fabricated by electropolymerizing poly(o-phenylenediamine) (oPD) on a gold electrode, followed
by Au-NP deposition and casting thiolated primary aptamers on the electrode surface. The tracing
tag was prepared by depositing gold NPs, thionine, and thiolated aptamers on SiO2@MWCNT
nanocomposites. Human epidermal growth factor receptors (HER) normally present in human
adults, however, their over expression indicate risk of cancer. HER2 is an indicator of breast cancer.
Arkan et al. [62] constructed a HER2 sensor by electrodepositing AuNPs onto MWCNT-carbon ionic
liquid electrode (CILE), attaching carboxyl-stabilized AuNPs via 1,6-hexanedithiol (HDT) linkers,
and immobilizing monoclonal anti-HER2 antibodies (Herceptin) on the electrode surface. Asav and
Sezgintürk [63] constructed a highly sensitive HER-3 biosensor by immobilizing anti-HER-3 antibodies
on the surface of a screen-printed carbon electrode (SPCE) modified with SWCNTs. Elevated
expression of matrix metalloproteinase-3 (MMP-3) is associated with squamous cell carcinoma of
the head and neck, and adrenal tumors. Munge et al. [64] constructed a MMP-3 sensor based on
SWCNT forest-primary antibody sensor platform and bioconjugate labels prepared by immobilizing
secondary MMP-3 antibodies and biotinylated HRP on polystyrene beds coated with streptavidin.
Alpha-fetoprotein (AFP) is a biomarker of hepatocellular carcinoma, one of the most common
malignant cancers. Tu et al. [65] fabricated an AFP sensor by drop casting an AuNP/CS solution on
GCE and immobilizing anti-AFP on CS. SWCNT-MnO2 tags conjugated with AFP were deposited on
the modified electrode surface for AFP detection. Yang et al. [66] constructed a label free AFP sensor
by drop-coating SWCNTs on SPCE and covalently linking wheat-germ agglutinin (WGA) lectin as
molecular recognition element to SWCNT. An ultrasensitive AFP sensor was developed by Li et al. [67]
by applying anti-AFP recognition elements on both the sensor surface and label. The working electrode
was fabricated by electrodepositing AuNPs on GCE and immobilizing AFP antibodies on the electrode
surface. The signal amplification label was prepared by depositing AuNPs, lead ions, and secondary
AFP antibodies on amino-functionalized MWCNT-Fe3O4.
Simultaneous detection of several biomarkers has an elevated diagnostic value. Choudhary et al. [68]
developed a biosensor for simultaneous detection of lung cancer biomarkers anti-MAGE A2 and
anti-MAGE A11 using multichannel electrochemical analyser having two working graphite (GR)
electrodes modified by SWCNT-CS composite in one reaction cell. Biomarker specific antigens were
immobilized on the composite surface separately. Sanchez-Tirado et al. [69] used p-aminobenzoic acid
functionalized double-walled carbon nanotubes (HOOC-Phe-DWCNT) to construct a sandwich-type
dual electrochemical platform for the simultaneous detection of factor necrosis tumor α (TNF-α)
and Interleukin 1β (IL-1β) in spiked serum and saliva. The electrode was prepared by casting
HOOC-Phe-DWCNT onto screen-printed carbon electrode (SPCE) and immobilizing capture antibodies
using commercial polymeric coating Mix&CoTM. Signal amplification was introduced by means of
biotinylated antibodies and poly-HRP-streptavidin conjugates.
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Table 1. CNT(Carbon nanotube)-based cancer biosensors.
Sensor Platform//Label Analyte Instr. Techn.a Linearity Range LOD References
Pt/SWCNT/anti-PSA PSA CHI n.a. 0.25 ng/mL [33]
GCE/starch-MWCNT-Nafion/AuNP/anti-PSA PSA CV 0.01–0.5, 0.5–3.0 ng/mL 7 pg/mL [34]
PG/SWCNT/anti-PSA//anti-PSA/MWCNT/HRP PSA AMP 0.4–40 ng/mL 4 pg/mL [35]
GCE/PPy@MWCNT/AuNP/anti-PSA//HRP-anti-PSA PSA DPV 0.002–20 ng/mL 1 pg/mL [36]
FET/CNT/anti-OPN OPN CHI 1 pg/mL–1 µg/mL 1 pg/mL [37]
Au/ITO/SWCNT/anti-OPN OPN CHI 1 pg/mL–1 µg/mL 0.3 pg/mL [38]
Au/SWCNT/NDI/SWCNT/AuNP/TSP-cDNA//AuNP-hemin-G-quadruplex DNAzyme miRNA-21 DPV 10 fM–1 nM 1.95 fM [39]
GCE/ox-MWCNT/poly(JUG-JUGA)/cDNA miRNA-141 SWV 10 fM–100 pM 8 fM [40]
GSPE/rGO/ox-MWCNT/cDNA//anti-miRNA/HRP-anti-miRNA miRNA-141 SWV 10 fM–1 nM 10 fM [41]
Au/SWCNT/protein p19 miRNA-122a CHI 1 aM–10 fM 1 aM [42]
GCE/CNT/NH2-HP DNA/CP/RCA miRNA let-7 DPV 10–1000 fM 1.2 fM [43]
GCE/MWCNT/cDNA miRNA-24 DPV 1 pM–1 nM, 1–10 nM 1 pM [44]
Au/CS-MWCNT-Thi/anti-CEA CEA DPV 1 pg/mL–100 ng/mL 0.5 pg/mL [45]
CP/PEDOT:PSS-CNT/anti-CEA CEA AMP 2–15 ng/mL n.a. [46]
GCE/(PB-NP/RGO-MWCNT)5/AuNP/anti-CEA CEA DPV 0.2–1, 1–40 ng/mL 60 pg/mL [47]
GCE/(PB-NP/MWCNT-PEI-AuNP)5/CS-AuNP/anti-CEA CEA AMP 0.5–2, 2–160 ng/mL 80 pg/mL [48]
GCE/(PDDA-MWCNT/PSS)2/PDDA-MWCNT/AuNP/anti-CEA CEA AMP 0.1–2, 2–160 ng/mL 60 pg/mL [49]
Au/L-Cys/anti-CEA//MWCNT/PDDA/HRP/ConA/HRP-anti-CEA CEA DPV 0.05–200 ng/mL 18 pg/mL [50]
SPCE/MWCNT/anti-CEA//AuNR/GlOx/anti-CEA CEA DPV 0.01–100 ng/mL 4.2 pg/mL [51]
GCE/RGO-MWCNT/Pt/anti-CEA//Pt/Fe@CD/anti-CEA CEA ECL 0.003–600 ng/mL 0.8 pg/mL [52]
ITO/MWCNT-PABA/anti-CEA//MWCNT-CR/C60/anti-CEA CEA PEC 0.001–100 ng/mL 0.1 pg/mL [53]
GCE/GS-NH2/anti-CEA//PdPt/MWCNT-NH2/anti-CEA CEA AMP 0.001–20 ng/mL 0.2 pg/mL [54]
GCE/MWCNT-ZnO/anti-CA125 CA125 DPV 0.001–1000 U/mL 0.00113 U/mL [55]
GCE/MWCNT-Nafion/Co(bpy)33+/AuNP/anti-CA125 CA125 CV 1–30, 30–150 U/mL 0.36 U/mL [56]
QCM/PLL/HA/MWCNT/anti-CA 19-9 CA 19-9 QCM 12.5–270 U/mL 8.3 U/mL [29]
Ta/MWCNT/AuNP/cDNA TP53 EIS 1 fM–100 nM 10 aM [57]
GCE/MWCNT-PA6-PTH/anti-AGp53//HRP@anti-AGp53 AGp53 DPV 2–2000 pg/mL 1 pg/mL [58]
GCE/MWCNT-PA6/PTH/ssDNA1//AuNP-ssDNA2 K-ras DPV 0.1–100 pM 30 fM [59]
FET/SWCNT-galactose Galectin-3 CHI 156–312.5 ng/mL n.a. [60]
Au/PoPD/AuNP/aptamer//aptamer/Thi/AuNP/SiO2@MWCNT MUC 1 DPV 1–100 nM 1 pM [61]
MWCNT-CILE/AuNP/HDT/AuNP/anti-HER2 HER2 EIS 10–110 ng/mL 7.4 ng/mL [62]
SPCE/SWCNT/anti-HER-3 HER-3 EIS 2–14 fg/mL 2 fg/mL [63]
PG/SWCNT/anti-MMP-3//anti-MMP-3/polystyrene/HRP MMP-3 AMP 4–300 pg/mL 4 pg/mL [64]
GCE/CS-AuNP/anti-AFP//HOOC-SWCNT-MnO2 AFP LSV 0.2–100 ng/mL 40 pg/mL [65]
SPCE/SWCNT/WGA AFP EIS 1–100 pg/mL 0.1 pg/mL [66]
GCE/AuNP/anti-AFP//Pb2+@Au@MWCNT-Fe3O4/anti-AFP AFP AMP 10 fg/mL–100 ng/mL 3.33 fg/mL [67]
GRT/SWCNT-CS/anti-anti-MAGE A2 or A11
anti-MAGE A2





1–200 pg/mL 0.85 pg/mL
[69]IL-1β 0.5–100 pg/mL 0.38 pg/mL
a Instrumental techniques: AMP = amperometry, EIS = electron impedance spectroscopy, FS = fluorescence sensor, CHI = chemiresistor, CHA = chronoamperometry,
CL = chemiluminescence, CV = cyclic voltammetry, DPASV = differential pulse anodic stripping voltammetry, DPV = differential pulse voltammetry, ECL = electrochemiluminescence,
LSV = linear sweep voltammetry, PEC = photoelectrochemical, PT = potentiometry, QCM = quartz crystal microbalance, SWV = square wave voltammetry, SWASV = square wave anodic
stripping voltammetry, n.a. = not available.
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3.1.2. CNT-Based Biosensors for Disease Biomarker Detection
Myoglobin (Mgb), Netrin 1, Myeloperoxidase (MPO), and cholesterol are important biomarkers
of cardiovascular disease and myocardial infarction. Khan et al. [70] constructed a label free Mgb
immunosensor by depositing monoclonal anti-Mgb antibodies onto the screen-printed-MWCNTs
electrode by adsorption technique. A sensitive netrin 1 biosensor was fabricated by Xu et al. [71] by
modifying GCE consecutively with MWCNT-chitosan (CS) composite film, thionine, gold NPs, and
immobilizing netrin 1 antibodies on the electrode surface to capture netrin 1. A disposable electrochemical
MPO biosensor was designed by Herrasti et al. [72] based on CNT/magnetic microparticles (MP)
concentrated on SPCE using a magnet. In order to construct the sensor, streptavidin-coated MPs were
modified with biotinylated anti-MPO antibodies, and SWCNTs were deposited onto MP surfaces for signal
amplification. A label free MPO immunosensor was developed by Lu et al. [73] by immobilizing anti-MPO
on GCE modified successively by DMF-MWCNTs-1-ethyl-3-methylimidazolium tetrafluoroborate
(EMIMBF4) and CS-CeO2NP composite films. Liu et al. [74] fabricated a sensitive and disposable
MPO-sensor based on modified ITO prepared by electropolymerizing a poly(o-phenylenediamine)
(PoPD)-MWCNT-EMIMBr composite film on ITO, depositing AuNPs on the film, and immobilizing
anti-MPO on AuNPs. Navamani et al. [75] prepared a sensitive cholesterol sensor by casting a film
containing Nafion, MWCNT, cholesterol oxidase (ChOx), and poly-N-vinyl-2-pyrrolidone (PVP)
encapsulated ZnS NPs onto GCE electrode.
The specific antibody of neuromyelitis optica disease targets aquaporin-4 (AQP4), a transmembrane
protein expressed in the central nerve system. Son et al. [76] constructed a CNT-FET functionalized
with AQP4 extracellular loop peptides for the rapid detection of AQP4 antibody in human serum.
Lyme antigens present in body fluids are key biomarkers of Lyme disease. Lerner et al. [77] developed
a sensitive and rapid biosensor based on antibody-functionalized SWCNT-FET for the detection of
Lyme antigens.
α-1 antitrypsin (AAT) and Amyloid-β (Aβ) are recognised biomarkers of Alzheimer’s disease.
Zhu and Lee [78] developed an aptamer-antigen-antibody sandwich-type AAT biosensor based on
3,4,9,10-perylenetetracarboxylic acid (PTCA)/CNT as sensing platform and alkaline phosphatase
(ALP)-labelled AAT antibody functionalized AgNPs as signal enhancer. The working electrode of
the sensor was constructed by drop casting PTCA-CNT on SPCE and immobilizing AAT specific
amino-terminated 37-mer DNA aptamers, on the electrode surface. Oh et al. [79] developed a
SWCNT-film based metal semiconductor FET for Aβ detection in human serum. Gold top gate
was deposited on the middle of the SWCNT channel, and Aβ antibodies were immobilized on the
gold layer using an antibody binding protein. Monitoring the level of acetylcholine and its precursor
choline in serum is very important to detect neurodegenerative diseases such as Alzheimer’s and
neuromuscular diseases. A bienzymatic choline biosensor was constructed by Pundir et al. [80] by
electrodepositing MWCNT and ZrO2 NPs on GCE, and co-immobilizing acetylcholinesterase (AChE)
and choline oxidase (ChlO) on the electrode surface.
Human sirtuin1 (SirT1) is biomarker of age-related diseases. An et al. [81] constructed
a SirT1 biosensor based on polymeric G4-polyamidoamine dendrimer (PAMAM)-Au-MWCNT
nanocomposites as electrode modifiers and core-shell SiO2@Au NP labels. HRP-anti-SirT1 and
anti-SirT1 antibodies were attached to labels and sensor surface, respectively, for sandwich-type
sensing. Serum anti-citrullinated peptide antibodies (ACPAs) are specific markers for rheumatoid
arthritis (RA) autoimmune disease. An electrochemical immunosensor device for the rapid detection
of ACPAs in human serum was developed by de Gracia Villa et al. [82]. The immunosensor composed
of MWCNT-polystyrene (PS) composite transducer and immobilized citrullinated specific peptide
receptors (CSPR) specific against autoantibodies present in RA patients. Signal amplification was
introduced using anti-human IgG secondary antibodies labelled with HRP. A RA-sensor based on
QCM sensing was developed by Drouvalakis et al. [83]. The sensor was prepared by drop-casting a
SWCNT film on QCM crystal and immobilizing CSPR on top of this film. Clostridium difficile toxin
B (Tcd B) is one of the causative agents of antibiotic-associated diarrhea. Fang et al. [84] constructed
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a sandwich-type immunosensor for Tcd B biomarker detection using a multienzyme amplification
strategy. The working electrode of the sensor was fabricated by LbL coating MWCNTs, Prussian blue
(PB), and CS on GCE, and immobilizing primary Ted B antibodies on the electrode surface. Signal
labels were prepared by immobilizing HRP conjugated Tcd B secondary antibody and HRP on GO.
Abnormal levels of dopamine (DA), uric acid (UA), or glucose in plasma and urine are indicators
of several diseases, for example Parkinson’s and Alzheimer’s disease, Lesch-Nyhan syndrome, and
diabetes. Anirudhan et al. [85] constructed a molecular imprinted polymer (MIP) modified copper
electrode for potentiometric detection of DA. MIP was prepared by selective polymerization of
acrylamide grafted MWCNTs with itaconic acid as functional monomer in the presence of DA using
ethylene glycol dimethacrylate as a cross-linker. Prasad et al. [86] fabricated a similar MWCNTs-MIP
based DA sensor, but used carbon ceramic electrode (CCE) (Table 2). Ali et al. [87] fabricated a
DA sensor with superior LOD of 40 pM by modifying a gold electrode with a thin layer of in situ
polymerized poly(anilineboronic acid) (PABA)/ssDNA-wrapped SWCNT composite and a thin layer of
Nafion film. The sensing approach combined the high permselectivity of Nafion and the high affinity of
DA to boronic acid. Canevari at al. [88] constructed a DA and UA biosensor by modifying the surface of
GCE with MWCNT/mesoporous silica composite film. A selective uricase (UOx)-based UA sensor was
fabricated by Chen et al. [89]. The working electrode of the sensor was prepared by casting SDBS-coated
SWNTs, depositing thionine, and immobilizing UOx, consecutively, on GCE surface. Wang and
Musameh [90] prepared a glucose sensor based on co-immobilization of MWCNT and glucose oxidase
(GlOx) within an electropolymerized polypyrrole (PPy) film on GCE. The sensor was able to measure
glucose concentration in the hyper-glycemia range. Valentini et al. [91] used SWCNTs instead of
MWCNTs and Au microelectrode instead of GCE for the fabrication of a similar CNT/PPy/GlOx
composite film based glucose electrode. The increased sensitivity and extended linearity of this sensor
(Table 2) provided possibility to measure glucose level useful also for hypo-glycemia disease.
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Table 2. CNT-based disease biosensors.
Sensor Platform//Label Analyte Instr. Techn.a Linearity Range LOD References
SPE-MWCNT//anti-Mgb myoglobin EIS 0.1–90 ng/mL 0.08 ng/mL [70]
GCE/c-MWCNT-CS/Thi/AuNP/anti-netrin 1 netrin 1 DPV 0.09–1800 pg/mL 0.03 pg/mL [71]
SPCE/MP-anti-MPO/SWCNT MPO CHA n.a. 55 ng/mL [72]
GCE/DMF-MWCNT-EMIMBF4/CS-CeO2NP/anti-MPO MPO CV 5–300 ng/mL 0.2 ng/mL [73]
ITO/PoPD-MWCNT-EMIMBr/AuNP/anti-MPO MPO CV 0.2–23 and 23–300 ng/mL 0.05 ng/mL [74]
GCE/Nafion-ZnS-c-MWCNT-ChOx cholesterol CV 1.3–11.6 mM 0.26 mM [75]
FET/CNT/loop peptide ab-AQP4 CHI n.a. 1 pg/mL [76]
FET/SWCNT/anti-ag-Lyme ag-Lyme CHI 1–3000 ng/mL 1 ng/mL [77]
SPCE/PTCA-MWCNT/AAT aptamer//ALP-anti-AAT/AgNP AAT DPV 0.05–20 pM 0.01 pM [78]
FET/SWCNT/Au/anti-amyloid-β amyloid-β CHI 1 pg/mL–1 ng/mL 1 pg/mL [79]
GCE/c-MWCNT/ZnO2-NP/AChE-ChlO choline CV 0.05–200 µM 0.01 µM [80]
GCE/PAMAM-AuNP-MWCNT/anti-SirT1//SiO2@Au NP/HRP-anti-SirT1 SirT1 DPV 20 pg/mL–500 ng/mL 12.5 pg/mL [81]
Au/c-MWCNT-PS/CFFCP1 peptide//anti-ACPA-HRP ACPA AMP n.a. n.a. [82]
Au/SWCNT/CSPR peptide//anti-ACPA ACPA QCM n.a. n.a. [83]
GCE/MWCNT/PB/CS/ anti-Tcd B//GO/HRP-anti-Tcd B/HRP Tcd B DPV 0.003–320 ng/mL 0.7 pg/mL [84]
Cu/MWCNTs-MIP dopamine PT 1–10,000 nM 1.0 nM [85]
CCE/MWCNTs-MIP dopamine DPASV 0.75–34 ng/mL 0.21 ng/mL [86]
Au/ssDNA-SWCNT/PABA/Nafion dopamine DPV n.a. 40 pM [87]
GCE/c-MWCNT/SiO2 dopamine DPV 0.5–6 µM 14 nM [88]
GCE/ox-MWCNT/SiO2 uric acid DPV 0.5–10 µM 0.068 µM [88]
GCE/SWCNT/Thi/UOx uric acid AMP 2 µM–2 mM 0.5 µM [89]
GCE/PPy/c-MWCNT/GlOx glucose AMP 4–50 mM 0.2 mM [90]
Au/SWCNT/PPy/GlOx glucose AMP 0.56–100 mM 0.05 mM [91]
a Instrumental techniques: see Table 1 for abbreviations.
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3.2. Graphene-Based Biomarker Biosensors
Graphenes (GO, rGO, GR) has unique electronic, adsorption, and fluorescence properties,
thus they emerged in the last decade as powerful key elements of biosensors for detecting
biomarkers [16,20,21,92–95]. Their properties can be finely tuned by controlled reduction or surface
modification. Electronic conductivity, for example, is gradually increasing in the order of GO–Rgo–GR,
but hydrophilicity is decreasing. The covalent functionalization of GO is especially simple due to
the presence of sufficient amounts of carboxyl groups. Graphenes adsorb strongly to certain groups
of biomolecules, and provide support for different targets. Graphenes quench fluorescence very
efficiently, what makes them indispensable elements of optical sensors.
3.2.1. Graphene-Based Biosensors for Cancer Biomarker Detection
The messenger RNA biomarker PCA3 is related to prostate cancer. Vilela et al. [96] constructed an
optical PCA3 biosensor based on NaYF4:Yb,Er upconversion NPs (UCNPs) as emitters linked to 25-mer
ssDNAs as capture probes, and GO as the fluorescence quencher. UCNPs retained their fluorescence
signal at the presence of target PCA3, because they did not interact with GO due to target-capture
DNA hybridization. Zhang et al. [97,98] fabricated chemiresistor-type FET biosensors for prostate
specific antigen (PSA) detection based on LbL self-assembled graphene composites. The multilayer
was prepared by immersing the substrate into charged suspensions of poly(diallyldiamine chloride)
(PDDA), poly(styrene sulfonate) (PSS), and graphene, and PSA capture antibodies were immobilized on
the top graphene layer to capture the target. Sensor performances were improved [98] by suppressing
flicker noise by suspending the graphene multilayer between gold electrodes of the sensor (Table 3).
Another proof of the advantage of suspended structure compared to polycrystalline GR flakes was
provided by Li et al. [99]. A FET biosensor based on suspended single crystalline graphene was
prepared for lung cancer tumor marker (ANXA2, ENO1, and VEGF) detection. Antibodies were
immobilized on graphene using poly-L-lysine. Sensor performance strongly increased due to the
absence of grain boundary and substrate scattering. Li et al. [100] constructed an ANXA2, ENO1,
and VEGF biosensor based on tunable graphene composites prepared by depositing PDDA, graphene,
and TiO2 layers on a shape memory polymer using the self-assembly technique. Lung cancer biomarker
capture antibodies were deposited on the surface of the composite for biomarker capture.
Carcinoembryonic antigen (CEA) is elevated in many malignancies. Liu et al. [25] constructed a
CEA sensor by preparing and modifying graphene foam (GF) electrode with polydopamine (pDA)
linker, concanavalin A (conA), and HRP-labelled anti-CEA antibodies using the lectin-mediated strategy.
The fabrication and detection process of the sensor is shown in Figure 4. Wen et al. [26] constructed a
sandwich-type CEA biosensor based on triplex signal amplification strategy and on oligonucleotide
aptamer capture probes. The sensor platform was prepared by casting a cetyltrimetylammonium
bromide (CTAB)-GR suspension on GCE, followed by a chitosan (CS)-streptavidin (SA) solution.
The bioconjugate labels were prepared by immobilizing thiolated and biotinylated hairpin (HP) DNA
probes and HRP on gold nanorods (AuNR). At the presence of CEA, HP loops opened-up and the
exposed biotins bonded to SA via avidin-biotin reaction. Multiplex sandwich-type immunosensors
for simultaneous detection of CEA and α-fetoprotein (AFP) were developed by Li et al. [101],
Chen et al. [102], and Wang et al. [103] by using different sensor materials and architectures,
and immobilizing anti-CEA and anti-AFP antibodies on both the sensor surface and labels. Superior
sensor performance was achieved by combining a polyaniline (PANI)/Au nanoparticles modified
paper working electrode (Au-PWE) with 3D-rGO@methylene blue (MB) and carboxyl ferrocene
(Fc-COOH) redox probe tracers [101], compared to CS-AuNPs modified GCE sensor platform with
toluidine blue (TB) and Prussian blue (PB) redox probes deposited on carboxyl graphene nanosheets
(CGS) [102] or ionic liquid reduced graphene oxide (IL-rGO) modified GCE sensor platform with
amino capped Pt porous NPs signal tags complexed separately with Cd2+ and Cu2+ ions for antibody
labelling [103]. A triple tumor marker immunosensor for simultaneous detection of CEA, PSA, and AFP
was developed by Xu et al. [104]. The biosensor was based on IL-rGO and PSS modified GCE and
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carbon-AuNP nanocomposite labels. Primary capture antibodies were immobilized on the modified
electrode surface. Biocomposite labels were prepared separately for the three target biomarkers by
adsorbing thionin (Thi), 2,3-diaminophenazine (DAP), and Cd2+ on CAuNPs, and immobilizing
anti-CEA, anti-PSA, and anti-AFP, respectively. Zhu et al. [105] constructed a sandwich-type biosensor
for simultaneous detection of CEA, AFP, CA125, and PSA based on hybridization chain reaction
(HCR) and biotin-streptavidin signal amplification strategy. The sensor platform was prepared by
immobilizing the four antibodies simultaneously on homogenous GR-Au multilayer film modified
GCE. Bioconjugate signal tags were prepared separately by linking secondary biotinylated antibodies,
SA, oligonicleotides for HCR, and redox probes labelled SA on Au/SiO2-Fe3O4 NPs. The sensor
exhibited high sensitivity for the simultaneous detection of the four biomarkers (Table 3).
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The human epidermal growth factor receptors ErbB2, HER2, and HER3 and carbohydrate
antigen 15-3 (CA 15-3) are biomarkers of breast cancer. Ali et al. [106] constructed a microfluidic
ErbB2 immunosensor based on porous GF electrode modified with electrospun carbon-doped TiO2
nanofibers and ErbB2 antibodies. Tabasi et al. [24] developed a HER2 specific aptamer-based HER2
immunosensor by depositing rGO-CS film on GCE and immobilizing amino-terminated aptamers on
this film. Methylene blue (MB) was used to probe biointerface events. Rajesh et al. [107] fabricated a
sensitive HER3 biosensor, what is based on graphene FET decorated with antibody-functionalized
PtNPs. PtNPs were attached to graphene using the bifunctional 1-methyl pyrene amine linker,
and thiol-containing single-chain variable fragment antibodies (scFv) were immobilized on PtNPs.
Akter et al. [108] constructed a sandwich-type CA 15-3 immunosensor using GO/1-pyrenecarboxylic
acid (Py-COOH) as sensor probe and MWCNT-supported ferritin as labels. GO/Py-COOH was
deposited on cysteamine (Cys) self-assembled monolayer (SAM) modified gold electrode, and anti-CA
15-3 antibodies were immobilized on both GO/Py-COOH and MWCNT/ferritin labels.
Mesothelin (MSLN) antigen is a biomarker for ovarian and pancreatic cancer. A sandwich-type
MSLN immunosensor was fabricated by Shiddiky et al. [109] based on high-density poly(N-isopropyl
acrylamide) (pNiPAM) antifouling brush modified ITO electrode and an electroactive label. Polyclonal
MSLN antibodies were immobilized on the terminus of the pNiPAM brushes using alkyne-azide
‘click’ reaction. The bioconjugate label was prepared by immobilizing amine-functionalized CdSe
QDs and SA on GO nanosheets, and linking single-chain variable antibody fragments (scFv)
of MSLN comprising only the antigen recognition region on CdSe-QD/GO labels utilizing the
streptavidin-biotin interaction. The tumor-associated glycoprotein TAG-72 (cancer antigen 72-4,
CA72-4) is a gastric cancer biomarker. Wu et al. [110] constructed a CA72-4 immunosensor by
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modifying GCE with rGO-tetraethylenepentamine (rGO-TEPA) for effective immobilization of
primary anti-CA72-4 antibodies, and adsorbing secondary anti-CA72-4 antibodies onto dumbbell-like
PtPd-Fe3O4 NPs to prepare labels. Tumor necrosis factor-alpha antigen (TNF-α) is a recognized tumor
marker and correlated with various diseases. Mazloum-Ardakani and Hosseinzadeh [111] developed
an enzyme-free TNF-α aptasensor based on Ag@Pt core-shell NPs functionalized rGO nanosheets
(Ag@Pt-rGOs) as labels and AuNPs functionalized rGO/chitosan (Au-rGO/CS) nanocomposite
modified SPCE as sensing platform. Thiolated TNF-α aptamers were immobilized on both Au-rGO/CS
and Ag@Pt NPs to capture TNF-α. Distinct miRNA expression patterns are associated with various
tumor types. Cheng et al. [112] developed a miRNA-21 biosensor applying thiolated ssDNA (DNA1)
and a biotin-labelled reporter ssDNA (DNA2) as target capturers and streptavidin-modified, Cd2+
functionalized titanium phosphate nanospheres (TiP-Cd2+) as labels. PEI-modified rGO/AuNP
composites were drop-casted on GCE and DNA1 was immobilized on AuNP via chemisorptions.
TiP-Cd2+ was attached to DNA2 via biotin-avidin conjugation as signal tag. Tu et al. [113] constructed
a miRNA-126 fluorescence sensor based on GO fluorescence quenching and site-specific DNA cleavage
of RsaI endonuclease. The assay is based on the fluorescence recovery of the 66-base FAM-labelled
probe ssDNA assembled on GO, after hybridization of ssNDA with miRNA-126 and cleavage of the
dsDNA by RsaI. Cai et al. [114] developed a miRNA let-7b biosensor based on AuNPs decorated
graphene FET. The sensor was fabricated by drop-casting rGO onto the sensing channel of FET,
depositing AuNPs onto the surface of rGO, and immobilizing target complementary peptide nucleic
acid (PNA) probe on AuNPs. Hizir et al. [115] constructed a two-colour fluorescence sensor for the
simultaneous detection of prostate cancer miRNA-21 and miRNA-141 biomarkers in body liquids.
The sensor is based on FAM-labelled anti-miR-21 and Cy5-labeled anti-miR-141 ssDNA. The working
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2014. Reproduced with permission from American Chemical Society.
i l t
i et al. [116] for thrombin detection, what was based on [Ru(2,2′-bipyridine)2 -
(2-methoxylphenyl)- midazo[4,5-f][1,10]phenanthroline)]2+ (RuOMO), GO, and a thro bin fi
ir Thrombin d tection was achi ved by restorati n of the fluorescence of RuOMO
pre-quenched by GO. The cyclin A2 protein i a progn st c indica or in early-stage cancers.
A fluor scence and an ele trochemical cyclin A2 biosensor were developed by Wang t al. [117] and
F ng e al. [118], res ectively. The optic l sensor was based on GO as the fluorescence quencher and o a
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fluorescent-labelled FITC-HAKRRLIF peptide as target recognition element [117]. The electrochemical
sensor was constructed by modifying GCE with meso-tetra(4-carboxyphenyl)porphyrin (TCPP)
modified chemically converted graphene (CCG) and immobilizing hexapeptide RWIMYF on the
surface as specific binding site for cyclin A2 [118]. This latter sensor exhibited higher sensitivity with
LOD of 0.32 pM. 8-hydroxy-2′-deoxyguanosine (8OHdG) is regarded as a cancer risk biomarker and
indicative of a number of other disorders, such as cardiovascular and neurodegenerative diseases,
and diabetes. Shahzad et al. [119] and Jia et al. [120] fabricated 8OHdG biosensors by modifying
GCE with S-doped rGO (SRGO) and ss-DNA functionalized GR nanosheets, respectively. Sensors
exhibited excellent electrocatalytic activity toward the oxidation of 8OhdG and comparable LOD and
detection range (Table 3). Monitoring L-lactate concentration is important for early diagnosis and
treatment of cancer, because tumor metabolism releases a high amount of lactate into the extracellular
space. Azzouzi et al. [121] developed a L-lactate biosensor by drop casting a mixture of rGO-AuNP
nanocomposite and L-lactate dehydrogenase (LDH) in a sol gel matrix onto SPCE. Folic acid protein
(FAP) is a biomarker of many human epithelial-derived tumors. He et al. [122] constructed a FAP
biosensor based on the strong binding affinity of FAP to folic acid (FA). The working electrode
was prepared by electrophoretic deposition of rGO onto a gold electrode and functionalizing rGO
with FA. The overexpression of matrix metalloproteinases (MMPs) is related to tumor invasion and
metastasis. Song et al. [123] developed a fluorescence turn-on sensor for MMP-2 detection by linking
amino-terminated fluorescein isothiocyanate-labelled peptide (Pep-FITC) to GO. The pre-quenched
fluorescence of the FITC was restored upon contact with MMP-2, because MMP-2 selectively cleaved
the peptide and FITC was released from the GO surface. The cytokeratin-19 fragment CYFRA-21-1
is a biomarker of oral cancer. Kumar et al. [124] constructed a biosensor based on zirconia decorated
rGO to detect CYFRA-21-1 in saliva. The sensor was fabricated by electrophoretic deposition of
3-aminopropyl triethoxy saline (APTES) functionalized nanostructured ZrO2 decorated rGO onto ITO
electrode and immobilizing anti-CYFRA-21-1 antibodies on the thin nanocomposite film. Squamous
cell carcinoma antigen (SCCA) is a tumor marker for cervical cancer. Wu et al. [22] and Gao et
al. [125] developed sandwich-type immunosensors for SCCA detection based on N-doped graphene
(N-GS)–chitosan composite film and N-GS film on GCE, respectively, using anti-SCCA. Pt-Fe3O4
and Pd-Au/carbon NPs were used as trace labels, respectively, and the latter sensor exhibited better
sensor performance with a LOD of 1.7 pg/mL [125]. The human tissue polypeptide antigen (hTPA)
is a universal tumor marker. Wang et al. [126] constructed a sandwich-type hTPA immunosensor by
immobilizing primary and secondary hTPA antibodies on GO modified GCE and Pd-Pt bimetallic
nanocrystals, respectively. The tumor specific growth factor (TSGF) is a malignant tumor biomarker.
A sandwich-type TSGF immunosensor was developed by Yu et al. [127] by modifying a GCE with
rGO-TEPA and primary TSGF antibodies. Sensor labels were fabricated by anchoring secondary
antibodies on Ag@CeO2 NP nanocomposite. The nuclear matrix protein 22 (NMP22) is a biomarker
for bladder cancer. A highly sensitive NMP22 immunosensor was developed by Ma et al. [128] by
immobilizing NMP22 antibodies on trimetallic AuPdPt NPs and depositing these bioconjugates on
rGO-TEPA modified GCE. Apolipoprotein A II protein (APOA2) is also a bladder cancer biomarker and,
similarly to NMP22, can be detected in urine. Chen et al. [129] developed an APOA2 biosensor based
on polycrystalline silicon nanowire field-effect transistor (poly-SiNW-FET) and magnetic graphene
(Fe3O4 NPs-rGO) with long-chain acid groups (MGLA). Anti-APOA2 antibodies were immobilized on
MGLA and this bioconjugate was immobilized on poly-SiNW-FET.
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Table 3. Graphene-based cancer biomarker biosensors.
Sensor Platform//Label Analyte Instr. Techn.a Linearity Range LOD References
GO/UCNP/ssDNA PCA3 FS n.a. 0.5 pM [96]
FET/(PDDA+PSS)2(PDDA+GR)5/anti-PSA PSA CHI 4 fg/mL–4 µg/mL 0.11 fM [97]
FET/(PDDA+PSS)2(PDDA+GR)5/anti-PSA PSA CHI 0.4 fg/mL–4 µg/mL 11 aM [98]




VEGF CHI 100 fg/mL–1 µg/mL 100 fg/mL [100]
GF/pDA/ConA/HRP-anti-CEA CEA DPV 0.1–750 ng/mL 90 pg/mL [25]
GCE/GR/SA-CS//HP-DNA-AuNR-HRP CEA DPV 5 pg/mL–50 ng/mL 1.5 pg/mL [26]
PWE/AuNPs/PANI/anti-CEA,anti-AFP//rGO/MB,Fc-COOH/
anti-CEA,anti-AFP CEA, AFP DPV 1 pg/mL–100 ng/mL 0.5 pg/mL, 0.8 pg/mL [101]
GCE/CS-AuNP/anti-CEA,anti-AFP//anti-CEA-TB-CGS/
anti-AFP-PB-CGS CEA, AFP DPV 0.5–60 ng/mL 0.1 ng/Ml, 0.05 ng/mL [102]
GCE/IL-rGO/anti-CEA,anti-AFP//anti-
CEA-PtNP-Cd2+,anti-AFP-PtNP-Cu2+ CEA, AFP DPV 0.05–200 ng/mL 0.002 ng/mL, 0.05 ng/mL [103]
GCE/IL-rGO/PSS/anti-CEA,anti-AFP,anti-PSA//anti-CEA-Thi-







48 fg/mL, 62 fg/mL, 77 fg/mL,
60 fg/mL [105]
GF-nTiO2/anti-ErbB2 ErbB2 DPV 1.0 fM–0.1 µM n.a. [106]
GCE/rGO-CS/aptamer/MB HER2 DPV 0.5–2, 2–75 ng/mL 0.21 ng/mL [24]
FET/GR/PtNP/scFv-anti-HER3 HER3 CHI 300 fg/mL–300 ng/mL 300 fg/mL [107]
Au/Cys/GO/Py-COOH/anti-CA 15-3//anti-CA 15-3/MWCNT/Ferritin CA 15-3 DPV 0.05–100 U/mL 0.009 U/mL [108]
ITO/APES/pNiPAM/anti-MSLN//scFv-MSLN/GO/CdSe QDs MSLN SWASV n.a. 0.5 pg/mL [109]
GCE/rGO-TEPA/anti-CA72-4//anti-CA72-4/ PtPd-Fe3O4 CA72-4 EIS 0.001–10 U/mL 0.0003 U/mL [110]
SPCE/AuNP-GR/CS/aptamer//aptamer-Ag@Pt-Gr TNF-α DPV 5–70 pg/mL 1.64 pg/mL [111]
GCE/PEI-RGO/AuNP/cDNA1//cDNA2/TiP-Cd2+/Ru(NH3)63+ miRNA-21 SWV 1 aM–10 pM 0.76 aM [112]
GO/FAM-ssDNA miRNA-126 FS 0.02–100 pM 3.0 fM [113]
FET/rGO/AuNP/PNA miRNA let7b CHI 10 fM–100 pM 10 fM [114]
GO/FAM-anti-miR-21/Cy5-anti-miR-141 ssDNA miRNA-21miRNA-141 FS n.a. 2.0 nM, 1.2 nM [115]
GO-RuOMO-aptamers thrombin FS 3.7–613 nM 0.76 nM [116]
GO/ FITC-HAKRRLIF cyclin A2 FS n.a. 0.5 nM [117]
GCE/CCG/TCPP/hexapeptide cyclin A2 EIS 0.5–10 pM 0.32 pM [118]
GCE/SRGO 8OHdG DPV 2 nM–20 µM 1 nM [119]
GCE/GR/ss-DNA 8OHdG CV 0.0056–1.155, 1.155–11.655,11.655–36.155 µM 0.875 nM [120]
SPCE/RGO-AuNP/LDH L-lactate AMP 0.01–5 mM 0.13 µM [121]
Au/rGO/FA FAP DPV 1–200 pM 1 pM [122]
GO/ Pep-FITC MMP-2 FS 10–150 ng/mL 2.5 ng/mL [123]
ITO/rGO-ZrO2/APTES/anti-CYFRA-21-1 CYFRA-21-1 DPV 2–22 ng/mL 0.122 ng/mL [124]
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Table 3. Cont.
Sensor Platform//Label Analyte Instr. Techn.a Linearity Range LOD References
GCE/N-GS/CS/anti-SCCA//anti-SCCA/Pt-Fe3O4 SCCA EIS 0.05–18 ng/mL 15.3 pg/mL [22]
GCE/N-GS/anti-SCCA//anti-SCCA/Pd-Au/C SCCA EIS 0.005–2 ng/mL 1.7 pg/mL [125]
GCE/GO/anti-hTPA//anti-hTPA/Pd-Pt NP hTPA EIS 0.005–15 ng/mL 1.2 pg/mL [126]
GCE/rGO-TEPA/anti-TSGF//anti-TSGF/Ag@CeO2 TSGF CV 0.5–100 pg/mL 0.2 pg/mL [127]
GCE/rGO-TEPA/AuPdPt NP/anti-NMP22 NMP22 DPV 0.04–20 U/mL 0.01 U/mL [128]
FET-poly-SiNW/MGLA-anti-APOA2 APOA2 CHI 19.5 pg/mL–1.95 µg/mL 6.7 pg/mL [129]
a Instrumental techniques: see Table 1 for abbreviations.
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3.2.2. Graphene-Based Biosensors for Disease Biomarker Detection
The amyloid beta (Aβ) peptide and mRNA BACE-1 are biomarkers of Alzheimer’s disease.
Kim et al. [130] developed a sensitive chemiresistor-type wafer-scale rGO biosensor for Aβ40 detection.
Aβ antibodies were immobilized on rGO for target capture. Vilela et al. [96] constructed a BACE-1
optical fluorescence turn-on biosensor based on BACE-1 complementary capture ssDNAs immobilized
on NaYF4:Yb,Er upconversion NPs (UCNPs) as emitters and GO as the fluorescence quencher (Table 4).
Cardiac troponin-I (cTnI) is a biomarker of acute myocardial infarction. A sandwich-type cTnI
biosensor was constructed by Liu et al. [131], what was based on GO-Ph-AuNP modified GCE as
sensing platform and GO tailored with ferrocene (FcGO) as signal reporter labels. cTnI capture
antibodies were immobilized on both the working electrode surface and FcGO labels using
aryldiazonium salt coupling chemistry. 3,3′,5-triiodothyronine (T3) is a widely used diagnostic
marker of thyroid disease. Liao et al. [132] constructed a T3 biosensor based on modified GCE
working electrode and GO bioconjugate labels. The sensing platform of the sensor was prepared by
electropolymerizing L-lysine (LL) on GCE, electrodepositing AuNPs, and immobilizing T3 antibodies
on the modified electrode surface. Labels were prepared by co-immobilizing Ru(bpy)32+ and T3
antibodies on Fe3O4 loaded GO nanosheets. Procalcitonin (PCT) is a diagnostic biomarker of
septicemia disease. Liu et al. [133] developed a sandwich electrochemical strategy for PCT detection.
The working electrode of the sensor was constructed by electrodepositing rGO-Au nanocomposite
film on GCE and immobilizing PCT antibodies on this film. Bioconjugate labels were prepared
by binding anti-PCT to thionine (Thi) and linking this complex to single-walled carbon nanohorns
(SWCNHs)/hollow Pt chains (HPtCs) together with HRP for dual synergy amplification. Estriol is one
of the estrogens produced in women and abnormal esteriol level is associated with various diseases.
Kushwaha et al. [134] designed a fluorescent estriol sensor based on fluorescence enhancement of GO
upon bonding of estriol, due to radiative energy transfer.
D-amino acids are biomarkers of various diseases, because normally only L-amino acids are involved
in physiological processes. D-Tyrosine (Tyr), for example, is a renal biomarker. Martín et al. [135]
constructed a biosensor for the analysis of D and L tyrosine and methionine by casting reduced
GO nanoribbons (RGONR) onto SPCE. The sensing strategy was based on a dual electrochemical and
enzymatic approach involving D-amino acid oxidase (DAAO) for D-amino acid sensing and direct
electrochemical sensing for the L-enantiomer. Abnormalities in insulin secretion and activity lead to
various types of diabetes and increased risk factors of various diseases. Yagati et al. [23] constructed
an insulin sensor based on silver nanoflower (AgNF) decorated rGO modified micro-disk electrode
arrays and anti-insulin antibodies anchored on the working electrode (Table 4).
Dopamine (DA) and uric acid (UA) are important biomarkers of various diseases; therefore
several sensor platforms were constructed for their detection. Sun et al. [136] fabricated a DA and
UA biosensor by drop-casting short GO nanoribbons (GONR) and Nafion suspension onto GCE.
A sensitive biosensor based on ZnO nanowire arrays/graphene foam (GF) composite modified ITO
electrode was developed by Yue et al. [137] for the selective detection of UA and DA in serum
(Table 4). A DA sensor based on 3D-rGO modified GCE was fabricated by Yu et al. [138]. The sensor
exhibited an excellent sensing performance and high selectivity. Liu et al. [139] constructed a DA
sensor based on assembled multilayer of polyamidoamine (PAMAM) dendrimer stabilized AuNPs
and polysodium 4-styrenesulfonate (PSS) functionalized rGO on GCE. The sensor exhibited excellent
sensing performance with a small LOD of 20 nM. Bai et al. [140] fabricated a DA sensor based on a GCE
modified by three layers of highly reduced GO film prepared by self-assembly from rGO dispersion at
the DMF-air interface through evaporation-induced water-assisted thin film formation. The three rGO
layers modified electrode exhibited higher activity to dopamine than a single layer modified electrode.
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Table 4. Graphene-based disease biomarker biosensors.
Sensor Platform//Label Analyte Instr. Techn.a Linearity Range LOD References
MEMS/rGO/anti-Aβ Aβ40 CHI 100 fg/mL–100 pg/mL 100 fg/mL [130]
GO/UCNP/ssDNA BACE-1 FS n.a. 0.5 pM [96]
GCE/GO-Ph-AuNP/anti-cTnI//FcGO/anti-cTnI cTnI SWV 0.05–3 ng/mL 0.05 ng/mL [131]
GCE/PLL/AuNP/anti-T3//Fe3O4@GO/Ru(bpy)32+/anti-T3 T3 ECL 0.1 pg/mL–10 ng/mL 0.03 pg/mL [132]
GCE/rGO-Au/anti-PCT//SWCNH/HPtC/Thi/anti-PCT/HRP PCT CV 1.0 pg/mL–2.0 ng/mL 0.43 pg/mL [133]
GO estriol FS 1.3–10 nM 1.3 nM [134]
SPCE/GONR/DAAO D-Tyr DPV 0.25–1.0 mM 60 µM [135]
ITO/rGO-AgNF/MPA/anti-insulin insulin EIS 1–1000 ng/mL 70 pg/mL [23]
GCE/GONR-Nafion dopamine DPV 0.1–8.5 µM 24 nM [136]
GCE/GONR-Nafion uric acid DPV 0.1–8.5 µM 98 nM [136]
ITO/GF/ZnO NWA dopamine DPV 0–40 µM 1 nM [137]
ITO/GF/ZnO NWA uric acid DPV 0–40 µM 1 nM [137]
GCE/3D-RGO dopamine DPV 5 µM–1 mM 0.17 µM [138]
GCE/(PDDA)1(PSS-RGO/PAMAM-AuNPs)20 dopamine DPV 1–60 µM 0.02 µM [139]
GCE/(rGO)3(Nafion) dopamine LSV 0.5–30 µM 0.2 µM [140]
GCE/rGO-PhNHOH/LDH L-lactate AMP 0–90 µM 2.5 µM [141]
GCE/rGO-CS/GlOx Glucose CV 2–22 mM 20 µM [142]
Au/[CS(NGR+GlOx)/ PSS/CS(NGR+GlOx] Glucose CHA 0.2–1.8 mM 64 µM [143]
GCE/(rGO/PDDA-PB/GlOx/PDDA-PB)3 Glucose AMP 0.1–6.5 mM 6 µM [144]
GCE/(PEI/PAA-rGO)3(PEI/GlOx)5 Glucose AMP 0 -10 mM 0.168 mM [145]
GCE/(IL-RGO/SA-RGO)5/IL-RGO/GlOx Glucose AMP 10–500 µM 3.33 µM [146]
GCE/GA-AuNP/GlOx Glucose AMP 50–450 µM 0.597 µM [147]
Pt/GO/GlOx/CS/PVA fiber Glucose CV 5 µM–3.5 mM 5 µM [148]
RGO/silk fiber/PtNP/GlOx Glucose AMP 10 µM–10 mM 1 µM [149]
GCE/rGO/MnCo2O4 fiber/GlOx Glucose AMP 0.005–800 µM 1 nM [150]
a Instrumental techniques: see Table 1 for abbreviations.
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Increased lactate level in serum is an indicator of several diseases. Manna and Raj [141] developed
a sensor to detect L-lactate by depositing p-nitrophenyl functionalized rGO on GCE, generating a
surface confined redox mediator (rGO-PhNHOH), and immobilizing L-lactate dehydrogenase (LDH)
on the electrode surface. The glucose detection in body fluids is essential for monitoring diabetes.
Glucose sensors, in general, are based on the immobilization of glucose oxidase (GlOx) on top of
modified electrode surfaces or on incorporation of GlOx into the modifying thin layer of the bare
electrode. Assembled graphene sheets provide a possibility to incorporate GlOx in between graphene
layers and to control layer thickness for improving sensor performances. Liu et al. [142] fabricated
a glucose sensor by self-assembling GlOx and CS functionalized graphene platelets on GCE by
electrostatic attraction. A glucose biosensor was fabricated by Barsan et al. [143] by self-assembling
positively charged CS containing GlOx and nitrogen doped graphene (NGR) with negatively charged
poly(styrene sulfonate) (PSS) on gold electrode. Yan et al. [144] constructed a glucose sensor by
assembling poly(diallyldimethylammonium chloride) protected Prussian blue NPs (PDDA-PB), GlOx,
and rGO on GCE. Zeng et al. [145] prepared a multilayer film on GCE by alternating deposition of
poly(ethyleneimine) (PEI), pyrene-grafted poly(acrylic acid) modified rGO (PAA-rGO), and GlOx.
Gu et al. [146] prepared a multilayer on GCE by self-assembling amine-terminated ionic liquid (IL)
modified rGO and sulfonic acid (SA) functionalized rGO sheets, followed by immobilizing GlOx
on the top layer. This latter sensor exhibited superior performance with LOD of 3.33 µM (Table 4).
Graphene aerogel (GA) possesses a much higher electrical conductivity than casted graphene powder,
because constituent graphene sheets are chemically bonded. A glucose sensor exhibiting a LOD of
0.597 µM was fabricated by Wang et al. [147] by casting GA/AuNPs onto GCE and immobilizing GlOx
in the aerogel framework. Electrospun fiber membranes often show superior performance in sensor
construction compared to casted film membranes due to very high porosity and large surface area.
Su et al. [148] fabricated a glucose sensor by electrospinning a mixture of poly(vinyl alcohol) (PVA),
CS, GO, and GlOx directly onto a Pt electrode and depositing a thin layer of Nafion onto the modified
electrode surface for anti-interference effects. Liang et al. [149] used single graphene coated silk fibers
for sensor construction. A composite film of these fibers was prepared by vacuum filtration of a mixed
solution of GO and silk fibers, followed by chemical reduction with ascorbic acid. Pt nanospheres
were electrochemically deposited onto the film surface and GlOx was immobilized on the electrode by
cross-linking to pre-deposited BSA. Zhang et al. [150] constructed a very sensitive glucose sensor with
a LOD of 1 nM by casting graphene decorated MnCo2O4 composite nanofibers onto GCE obtained
by calcinating electrospun rGO/Mn(Ac)2/Co(Ac)2/polyvinyl pyrrolidone (PVP) composite fibers at
high temperature.
3.3. Carbon Quantum-Dot-Based Biomarker Biosensors
The application of carbon quantum-dots in the construction of biomaker sensors is currently in its
initial stage [17]. Graphene QDs were used to date to construct electrochemiluminescence (ECL) and
fluorescence biosensors (Table 5).
A label-free ECL immunosensor was developed by Wu et al. [151] for PSA quantification by
depositing Au/Ag-rGO modified with aminated GR-QDs and GO-QDs onto GCE and immobilizing
anti-PSA on the sensor surface. Dong et al. [152] constructed a label-free biosensor for CEA detection
by modifying a GCE with rGO-QD-AuNP nanohybrids and immobilizing anti-CEA on the electrode
surface. An improved CEA sensor reaching a LOD of 0.6 pg/mL was developed by Li et al. [153] using
nanoporous gold/chitosan modified paper working electrode (PWE) as sensor platform and GO-QD
functionalized Au@Pt core-shell NPs as signal labels, as well as anti-CEA antibodies immobilized
on both the sensor surface and labels. The LOD of this sensor was comparable to those of best
performing CNT and graphene based electrochemical sensors. A sensitive ECL immunosensor was
fabricated by Yang et al. [154] for the detection of carbohydrate antigen 199 (CA199). The sensor
platform was prepared by modifying GCE with Au and Ag NPs-modified rGO, and immobilizing
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anti-CA199 on the sensor surface. Signal amplification was based on anti-CA199 immobilized on
GO-QD modified PtPd-nanochains.
Zhao et al. [155] constructed a fluoroimmunoassay based on the regulation of the resonance
energy transfer (RET) between rGO acceptors and GO-QD donors for human immunoglobulin G
(IgG) detection. Anti-IgG antibodies were immobilized on GO-QDs, what adsorbed on rGO quencher,
but released from rGO upon interaction with target IgGs. Al-Ogaidi et al. [156] developed a sensitive
biosensor for the detection of the ovarian cancer biomarker CA125 utilizing the chemiluminescence
RET to graphene QDs. QDs were immobilized on glass chips and anti-CA125 antibodies were linked
to QDs through amide conjugation. Horseradish peroxidase (HRP)-labelled anti-CA125 antibodies
were used as signal labels (see Figure 6).
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GCE/Au/Ag-rGO/GR-QD/
GO-QD/anti-PSA PSA ECL 0.001–10 ng/mL 0.29 pg/mL [151]
GCE/rGO-QD/AuNP/anti-CEA CEA ECL 0.02–80 ng/mL 10 pg/mL [152]
PWE/Au/CS/anti-CEA/
/anti-CEA/GO-QD/Au@PtNP CEA ECL 0.001–10 ng/mL 0.6 pg/mL [153]
GCE/PVP-rGO/AgNP/AuNP/
anti-CA199//anti-CA199/GO-QD/PtPdNPs CA199 ECL 0.002–70 U/mL 0.96 mU/mL [154]
rGO/GO-QD/anti-IgG IgG FS n.a. 10 ng/mL [155]
GO-QD/anti-CA125/ /anti-CA125-HRP CA125 CL 0.1–600 U/mL 0.05 U/mL [156]
a Instrumental techniques: see Table 1 for abbreviations.
4. Conclusions and Outlook
The development of devices for early detection of diseases and treatment monitoring is of vital
importance for clinical diagnosis and therapy. Biomarkers of diseases provide valuable information,
however, their sensitive and reliable point-of-care measurement is challenging due to their low
concentration in complex biological media. The sensitivity of electrochemical and optical biosensors
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now reached the limit of detecting biomarkers in body fluids in very low concentration, what provides
a route for the routine application of non- or minimally invasive sampling techniques based on
blood, urine, saliva, tear, and sweat. Thus biosensors have the potential to provide cheap, fast,
highly accurate, sensitive, and reproducible results, and require only minimal technical expertise
and system maintenance. These sensors have shown to be overcome obstacles of classical techniques
involving invasive biopsies, expensive and complex labelling processes, and time-consuming analysis.
A wide variety of sensing techniques are used currently for biomarker detection. It is difficult,
however, to recommend which detection method is the most appropriate. The selection is not obvious,
taking into account many parameters including the analyte, sample matrix, assay format, labelling
requirements, miniaturizations and cost. Since electrode material and architecture play critical roles in
sensor performances, great efforts have been done to develop new sensor platforms by introducing new
materials. Carbon nanotubes and graphenes became essential elements of sensor platforms during the
last decade due to their excellent electrical, mechanical, and optical properties, and it is expected that
novel functionalization will expand their application possibilities. Carbon quantum dots are promising
new platform elements and more attention is expected for these nanomaterials in the future. There has
been a quest for detection limit in the past, but facile and economical considerations for sensor designs
are getting more and more important. Most of sensor developments thus far have considered the
detection of a single target. However, simultaneous measurement of multiple biomarkers can improve
the diagnostic value, because many of disease markers are indicative of multiple diseases. Development
of multi-analyte immunosensors are still in its early stage, and future researches are expected to move
into this direction. The antibody-antigen interaction is very specific and this is the method of choice
currently for recognition element designs of biosensors. Antibodies, however, are expensive and efforts
are made to replace antibodies with cheaper and more stable recognition elements, such as aptamers,
engineered single-chain variable antibody fragments, and organic molecules.
There is a large number of biosensors developed in recent years that are able to provide sensitivity
and selectivity requirements related for practical applications, however, this is not enough for
translation into industrial production and commercialization. Complicated sensor assembly processes,
expensive materials, possible undesired properties at nanoscale and lack of storage stability are
some limiting factors that preventing their mass production. Methods for producing identical sensor
batches and scaling-up to mass production, as well as integration of biosensors into automated and
miniaturized systems are yet to be developed. In addition, many of currently developed biosensors are
not validated using large numbers of patient samples. Although carbon based biosensors research for
cancer and disease detection is currently still at advanced laboratory stage, it has already provided a
promise and vision about future disease diagnosis and health monitoring. Further progress in this field
is expected to lead to development of biomarker sensors for routine clinical applications. Therefore,
based on current progress, there is a bright future for carbon nanomaterial-based biosensors and their
development along with involvement of new biomarkers will continue.
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